MICHAEL A DAVIES to Mitogen-Activated Protein Kinase 1
This is a "connection" page, showing publications MICHAEL A DAVIES has written about Mitogen-Activated Protein Kinase 1.
Connection Strength
0.031
-
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial. JAMA Oncol. 2016 Aug 01; 2(8):1056-64.
Score: 0.031